Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hypertensive Emergency-associated Hemolytic Uremic Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05726916

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Hemolytic and uremic syndrome (HUS) is a clinic-biological syndrome related to thrombotic microangiopathy affecting predominantly the kidney. Atypical HUS (aHUS…

France66 participantsStarted 2023-11-09

Treatment: Soliris®, Renin angiotensin system blockers

Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

All recent trials (1 shown)